$Harmony(HRMY)$ 收购$Zynerba制药(ZYNE)$

HRMY announced a definitive agreement to acquire Zynerba Pharmaceuticals for $1.1059 per share in cash, or $60 million, plus one non-tradeable contingent value right (CVR) per share, to receive potential additional payments of up to $140 million in the aggregate.